After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, JNJ falls under the Healthcare sector while operating within the Drug Manufacturers – General industry segment. The current market capitalization of Johnson & Johnson is $380.49B. A total of 8.46 million shares were traded on the day, compared to an average of 7.04M shares.
In the most recent transaction, Broadhurst Vanessa sold 8,891 shares of JNJ for 162.16 per share on Mar 13 ’24. After the transaction, the EVP, Global Corp Affairs now owns 15,043 company shares. In a previous transaction on Feb 16 ’24, JOHNSON & JOHNSON sold 3,725 shares at 25.81 per share. JNJ shares that 10% Owner owns now total 4,099,575.
Among the insiders who sold shares, Taubert Jennifer L disposed of 59,397 shares on Feb 09 ’24 at a per-share price of $156.27. This resulted in the EVP, WW Chair, Pharmaceuticals holding 141,416 shares of JNJ after the transaction. In another insider transaction, Hait William sold 14,698 shares at $172.00 per share on Jul 26 ’23. Company shares held by the insider now total 87,747.
Dividend
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Johnson & Johnson pays an annual dividend of $4.76, resulting in a dividend yield of 3.01%, and it has a price to earnings (P/E) ratio of 28.32. JNJ’s most recent ex-dividend date was 2/16/2024 when it declared a $1.19 quarterly dividend that was paid in cash on 3/5/2024. Previously, the company paid the dividend on 12/5/2023 with an ex-dividend date of 11/20/2023. The JNJ stock dividend was $1.19 per share in cash.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, JNJ has a high of $175.97 and a low of $144.95.
As of this writing, JNJ has an earnings estimate of $2.63 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of $2.74 per share and a lower estimate of $2.44. The company reported an EPS of $2.66 in the last quarter, which was 5.60% higher than expectations of $2.52.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. JNJ’s latest balance sheet shows that the firm has $31.61B in Cash & Short Term Investments as of fiscal 2021. There were $33.75B in debt and $45.23B in liabilities at the time. Its Book Value Per Share was $28.57, while its Total Shareholder’s Equity was $74.02B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JNJ is Buy with a score of 3.90.
